CIK: 0001831942
Total reported value
$1.7B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RLAY | Relay Therapeutics INC | Stock-Other | 9.57% | +0.22% | — | |
| 2 | ALKS | Alkermes plc | Stock-Healthcare | 6.61% | +1.98% | +14.64% | |
| 3 | TYRA | Tyra Biosciences INC | Stock-Other | 5.91% | -0.43% | — | |
| 4 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 5.37% | -2.59% | -33.33% | |
| 5 | SYRE | Spyre Therapeutics INC | Stock-Other | 5.21% | +0.37% | +20.13% | |
| 6 | COGT | Cogent Biosciences INC | Stock-Other | 5.19% | +1.24% | -69.70% | |
| 7 | ELVN | Enliven Therapeutics INC | Stock-Other | 4.81% | +2.62% | — | |
| 8 | CLDX | Celldex Therapeutics INC | Stock-Other | 4.64% | +0.31% | -15.30% | |
| 9 | AMLX | Amylyx Pharmaceuticals INC | Stock-Other | 4.54% | — | +38.63% | |
| 10 | 430 | Terns Pharmaceuticals INC | Stock-Other | 3.97% | -3.97% | EXIT | |
| 11 | KYMR | Kymera Therapeutics INC | Stock-Other | 3.88% | -0.27% | — | |
| 12 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 3.70% | -2.44% | -11.11% | |
| 13 | NUVL | Nuvalent Inc-a | Stock-Other | 3.68% | +1.26% | -60.71% | |
| 14 | ORKA | Oruka Therapeutics INC | Stock-Other | 3.54% | -3.54% | EXIT | |
| 15 | PHVS | Pharvaris N.V. | Stock-Other | 3.49% | -0.35% | -21.87% | |
| 16 | NRIX | Nurix Therapeutics INC | Stock-Other | 2.87% | -0.83% | -39.82% | |
| 17 | PTGX | Protagonist Therapeutics INC | Stock-Other | 2.62% | -2.62% | EXIT | |
| 18 | ASMB | Assembly Biosciences INC | Stock-Other | 2.26% | -0.65% | — | |
| 19 | LBRX | Lb Pharmaceuticals INC | Stock-Other | 2.22% | -0.08% | — | |
| 20 | CTMX | Cytomx Therapeutics INC | Stock-Other | 2.18% | -2.18% | EXIT | |
| 21 | ANRO | Alto Neuroscience INC | Stock-Other | 2.16% | +1.38% | — | |
| 22 | PALI | Palisade Bio INC | Stock-Other | 1.79% | -1.06% | — | |
| 23 | BRD1EUR | Mind Medicine Mindmed INC | Stock-Other | 1.78% | -1.78% | EXIT | |
| 24 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 1.66% | -1.66% | EXIT | |
| 25 | PEPG | Pepgen INC | Stock-Other | 1.47% | -1.01% | +44.23% | |
| 26 | SABS | Sab Biotherapeutics INC | Stock-Other | 1.10% | -0.12% | — | |
| 27 | REPL | Replimune Group INC | Stock-Other | 0.92% | -0.92% | EXIT | |
| 28 | IKT | Inhibikase Therapeutics INC | Stock-Other | 0.74% | -0.22% | — | |
| 29 | CTNM | Contineum Therapeutics Inc-a | Stock-Other | 0.62% | -0.62% | EXIT | |
| 30 | AVTX | Avalo Therapeutics INC | Stock-Other | 0.58% | -0.16% | — | |
| 31 | RAPT | Rapt Therapeutics INC | Stock-Other | 0.56% | -0.56% | EXIT | |
| 32 | LONA | Leonabio INC | Stock-Other | 0.23% | +0.05% | — | |
| 33 | DRUG | Bright Minds Biosciences INC | Stock-Other | 0.10% | -0.10% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RLAY | Relay Therapeutics INC | +5.2% | — | Unchanged |
| 2 | TYRA | Tyra Biosciences INC | +3.6% | — | Unchanged |
| 3 | SYRE | Spyre Therapeutics INC | +3.6% | +20.13% | Add |
| 4 | ALKS | Alkermes plc | +2.1% | +14.64% | Add |
| 5 | ORKA | Oruka Therapeutics INC | +1.9% | — | Unchanged |
| 6 | 430 | Terns Pharmaceuticals INC | +1.9% | -74.12% | Trim |
| 7 | AMLX | Amylyx Pharmaceuticals INC | +1.8% | +38.63% | Add |
| 8 | KYMR | Kymera Therapeutics INC | +1.8% | — | Unchanged |
| 9 | NRIX | Nurix Therapeutics INC | +1.2% | -39.82% | Trim |
| 10 | LBRX | Lb Pharmaceuticals INC | +1.1% | — | Unchanged |
| 11 | ASMB | Assembly Biosciences INC | +1% | — | Unchanged |
| 12 | CTMX | Cytomx Therapeutics INC | +1% | — | Unchanged |
| 13 | PEPG | Pepgen INC | +0.9% | +44.23% | Add |
| 14 | CLDX | Celldex Therapeutics INC | +0.8% | -15.30% | Trim |
| 15 | SABS | Sab Biotherapeutics INC | +0.7% | — | Unchanged |
| 16 | PHVS | Pharvaris N.V. | +0.5% | -21.87% | Trim |
| 17 | IKT | Inhibikase Therapeutics INC | +0.3% | — | Unchanged |
| 18 | AVTX | Avalo Therapeutics INC | +0.3% | — | Unchanged |
| 19 | ELVN | Enliven Therapeutics INC | +0.1% | — | Unchanged |
| 20 | COGT | Cogent Biosciences INC | +0.1% | -69.70% | Trim |
| 21 | XENE | Xenon Pharmaceuticals INC | +0.1% | -33.33% | Trim |
| 22 | BRD1EUR | Mind Medicine Mindmed INC | -0.1% | -37.98% | Trim |
| 23 | PTGX | Protagonist Therapeutics INC | -0.7% | -56.10% | Trim |
| 24 | SLNOEUR | Soleno Therapeutics INC | -0.8% | -11.11% | Trim |
| 25 | DRUG | Bright Minds Biosciences INC | -1.4% | -96.23% | Trim |
| 26 | 260 | Centessa Pharmaceuticals-adr | -1.7% | -64.91% | Trim |
| 27 | NUVL | Nuvalent Inc-a | -2.2% | -60.71% | Trim |
| 28 | ✓ | Merus N V | — | EXIT | Sold out |
| 29 | AGIO | Agios Pharmaceuticals INC | — | EXIT | Sold out |
| 30 | VRDN | Viridian Therapeutics INC | — | EXIT | Sold out |
| 31 | CDTX | Cidara Therapeutics INC | — | EXIT | Sold out |
| 32 | ANRO | Alto Neuroscience INC | — | NEW | New buy |
| 33 | PALI | Palisade Bio INC | — | NEW | New buy |
| 34 | REPL | Replimune Group INC | — | NEW | New buy |
| 35 | TNGX | Tango Therapeutics INC | — | EXIT | Sold out |
| 36 | APGE | Apogee Therapeutics INC | — | EXIT | Sold out |
| 37 | ENTA | Enanta Pharmaceuticals INC | — | EXIT | Sold out |
| 38 | CTNM | Contineum Therapeutics Inc-a | — | NEW | New buy |
| 39 | RAPT | Rapt Therapeutics INC | — | NEW | New buy |
| 40 | ✓ | — | EXIT | Sold out | |
| 41 | VTGN | Vistagen Therapeutics INC | — | EXIT | Sold out |
| 42 | ✓ | Crescent Biopharma INC. | — | EXIT | Sold out |
| 43 | LONA | Leonabio INC | — | NEW | New buy |